Daniel M. Quirk MD

Vice President US Medical Affairs, Immunology and Fibrosis

Bristol Myers Squibb3401 Princeton PikeLawrence Township, NJ 08648

Dr. Quirk is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Quirk's full profile Already have an account?

Education & Training

Mass General Brigham/Massachusetts General HospitalFellowship, Gastroenterology, 1994 - 1997
Johns Hopkins UniversityResidency, Internal Medicine, 1991 - 1994
The Warren Alpert Medical School of Brown UniversityClass of 1991

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

PA State Medical License 2008 - 2026

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Care360 EHR, MedPlus, A Quest Diagnostics Company, 2014-2016
CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR, Allscripts, 2014-2016
CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR, Allscripts, 2014-2016

Publications & Presentations

PubMed

14 citations
Retrospective Database Analysis: Dose Escalation and Adherence in Patients Initiating Biologics for Ulcerative Colitis.
Millie D Long, Russell D Cohen, Timothy W Smith, Marco DiBonaventura, David Gruben
Digestive Diseases. 2022-01-01
311 citations
Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia.
Patrícia O. Guimarães, Daniel Quirk, Remo H. Furtado, Lilia N. Maia, José F. Saraiva
The New England Journal of Medicine. 2021-07-29
25 citations
Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib-Implications for Cardiovascular Risk and Patient Management.
Bruce E. Sands, Jean-Frederic Colombel, Christina Ha, Michel Farnier, Alessandro Armuzzi
Inflammatory Bowel Diseases. 2021-05-17

Press Mentions

Bristol Myers Squibb Presents New Data from Two Trials Demonstrating Sotyktu (Deucravacitinib) Efficacy in Both Moderate-to-Severe Scalp Psoriasis and in a Real-World SettingSeptember 27th, 2024
Philadelphia's Thomas Jefferson University Hospital Opens Barrett's Esophagus Treatment CenterFebruary 13th, 2016
Biogen Announces Upcoming Kidney Presentations at European Renal Association and American Transplant CongressesJune 5th, 2026